Carewell Pharmapack International Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 27-10-2024
- Paid Up Capital ₹ 4.01 Cr
as on 27-10-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 234.62%
(FY 2023)
- Profit 2.34%
(FY 2023)
- Ebitda 199.23%
(FY 2023)
- Net Worth 5.07%
(FY 2023)
- Total Assets 19.40%
(FY 2023)
About Carewell Pharmapack International
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chetan Sobti, Rajan Gupta, Kiran Sobti, and One other member serve as directors at the Company.
- CIN/LLPIN
U26109HR2020PTC085456
- Company No.
085456
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Carewell Pharmapack International?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saaran Bansal  | Director | 18-Feb-2020 | Current |
| Chetan Sobti | Director | 24-Apr-2023 | Current |
| Rajan Gupta | Director | 18-Feb-2020 | Current |
| Kiran Sobti | Director | 18-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Carewell Pharmapack International.
Carewell Pharmapack International Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 234.62% increase. The company also saw a slight improvement in profitability, with a 2.34% increase in profit. The company's net worth moved up by a moderate rise of 5.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Carewell Pharmapack International?
In 2023, Carewell Pharmapack International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Carewell Pharmapack International?
Carewell Pharmapack International has a workforce of 80 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carewell Pharmapack International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carewell Pharmapack International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
